GlaxoSmithkline Consumer Healthcare (GSKCH) today posted 10.73% rise in net profit at Rs 59.10 crore for the fourth quarter ended December, 2011.
The company had posted a net profit of Rs 53.37 crore in the corresponding period of previous fiscal.
Net sales of the company rose to Rs 602.05 crore for the fourth quarter ended December 31, 2011, compared to Rs 507.76 crore in the same period previous fiscal, GlaxoSmithkline said in filing to the Bombay Stock Exchange (BSE).
Commenting on the results, GSKCH Managing Director Zubair Ahmed said: "Despite high inflation in commodities, cost engineering programme helped the company deliver superior results."
The company's board, which met today, recommended a dividend at the rate of Rs 35 per equity share of Rs 10 each for the year ended December 31, 2011.
For the year ended December 31, 2011, the company posted a net profit of Rs 355.21 crore, compared to Rs 299.85 crore in the corresponding period of previous fiscal.
The company said it has appointed Jaiboy John Phillips as a wholetime director of the company with effect from today in the casual vacancy caused by the resignation of Director- Operations Praveen K Gupta.
Shares of GSKCH today closed at Rs 2,636.60 on the BSE, down 0.37% from previous close.
